Nuveen’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$804K Hold
234,946
﹤0.01% 3051
2026
Q1
$536K Buy
234,946
+43,401
+23% +$99.9K ﹤0.01% 2813
2025
Q4
$536K Sell
191,545
-72,371
-27% -$259K ﹤0.01% 2844
2025
Q3
$1.27M Buy
263,916
+16
+0% +$102 ﹤0.01% 2506
2025
Q2
$2.4M Sell
263,900
-149,087
-36% -$1.1M ﹤0.01% 2223
2025
Q1
$3.73M Buy
412,987
+154,044
+59% +$1.63M ﹤0.01% 2067
2024
Q4
$3.38M Sell
258,943
-28,439
-10% -$379K ﹤0.01% 2159
2024
Q3
$4.51M Buy
287,382
+1,633
+0.6% +$24.7K ﹤0.01% 2037
2024
Q2
$3.86M Sell
285,749
-577,996
-67% -$11.8M ﹤0.01% 2078
2024
Q1
$23.9M Sell
863,745
-240,304
-22% -$5.34M 0.01% 1064
2023
Q4
$21.3M Sell
1,104,049
-183,964
-14% -$3.33M 0.01% 1118
2023
Q3
$20.8M Sell
1,288,013
-912
-0.1% -$16.2K 0.01% 1017
2023
Q2
$24.5M Buy
1,288,925
+492,348
+62% +$8.78M 0.01% 953
2023
Q1
$11.6M Sell
796,577
-131,987
-14% -$2.36M ﹤0.01% 1397
2022
Q4
$18.1M Buy
928,564
+684,102
+280% +$13.3M 0.01% 1107
2022
Q3
$5.89M Sell
244,462
-199,543
-45% -$6.15M ﹤0.01% 1806
2022
Q2
$14M Sell
444,005
-95,162
-18% -$3.45M 0.01% 1301
2022
Q1
$24.6M Sell
539,167
-150,201
-22% -$6.45M 0.01% 1058
2021
Q4
$30M Sell
689,368
-45,483
-6% -$1.78M 0.01% 981
2021
Q3
$23M Sell
734,851
-89,266
-11% -$3.51M 0.01% 1168
2021
Q2
$34.9M Buy
824,117
+16,746
+2% +$652K 0.01% 962
2021
Q1
$30.3M Buy
807,371
+259,581
+47% +$8.12M 0.01% 1024
2020
Q4
$14.8M Sell
547,790
-10,608
-2% -$273K 0.01% 1442
2020
Q3
$14M Buy
558,398
+154,280
+38% +$2.25M 0.01% 1281
2020
Q2
$3.08M Buy
404,118
+52,548
+15% +$385K ﹤0.01% 2146
2020
Q1
$3.22M Buy
351,570
+68,508
+24% +$413K ﹤0.01% 1950
2019
Q4
$1.46M Buy
283,062
+7,177
+3% +$46.1K ﹤0.01% 2546
2019
Q3
$1.6M Sell
275,885
-10,623
-4% -$47.6K ﹤0.01% 2503
2019
Q2
$917K Buy
+286,508
New +$977K ﹤0.01% 2778
2017
Q2
Sell
-20,992
Closed -$726K 1249
2017
Q1
$726K Sell
20,992
-6,728
-24% -$240K ﹤0.01% 1069
2016
Q4
$978K Sell
27,720
-1,783
-6% -$60.3K 0.01% 1158
2016
Q3
$1.02M Hold
29,503
0.01% 1073
2016
Q2
$1.1M Buy
29,503
+200
+0.7% +$7.52K 0.01% 996
2016
Q1
$1.18K Sell
29,303
-668
-2% -$24.9K 0.01% 966
2015
Q4
$1.08K Sell
29,971
-182
-0.6% -$6.58K 0.01% 1035
2015
Q3
$963 Hold
30,153
0.01% 1107
2015
Q2
$1.02K Sell
30,153
-225
-0.7% -$7.58K 0.01% 1154
2015
Q1
$1.03M Hold
30,378
0.01% 1151
2014
Q4
$1.07M Sell
30,378
-197
-0.6% -$6.63K 0.01% 1152
2014
Q3
$1M Buy
30,575
+912
+3% +$31K 0.01% 1144
2014
Q2
$1.01M Sell
29,663
-187
-0.6% -$6.41K 0.01% 1168
2014
Q1
$1.05M Hold
29,850
0.01% 1117
2013
Q4
$1.09M Buy
29,850
+382
+1% +$14K 0.01% 1063
2013
Q3
$1.02M Buy
29,468
+1,624
+6% +$56.8K 0.01% 1096
2013
Q2
$942K Buy
+27,844
New +$924K 0.01% 1059

Other funds holding ACH

Nuveen's ACH Position: Q2 2026 in Review

Nuveen held its Accendra Health (ACH) position steady in Q2 2026 at 234,946 shares worth $804K. The position accounts for ﹤0.01% of the portfolio, ranked #3051.

Nuveen first reported a position in ACH in Q2 2013 and has held it in 45 quarters since. The position peaked at $34.9M in Q2 2021. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • Nuveen held 234,946 shares of Accendra Health worth $804K as of Q2 2026.
  • Nuveen left its Accendra Health share count unchanged in Q2 2026.
  • Accendra Health made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #3051 holding.
  • Nuveen first reported a position in Accendra Health in Q2 2013 and has held it in 45 quarters since.
  • Nuveen's Accendra Health position peaked at $34.9M in Q2 2021.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.